Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model

<div>Quantitative analysis of neointimal thickness/StrCSA and % neointimal area/StrCSA. There were no significant differences in neointimal thickness/StrCSA (a) and % neointimal area/StrCSA (b) between Promus PREMIER™ (<i>n</i> = 5) and Synergy™ (<i>n</i> = 5) on the 2<sup>nd</sup> day and 14<sup>th</sup> day. StrCSA: strut cross-sectional area.</div>

Journal of Interventional Cardiology

fig5

Figure 5

Figure 5: Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model 

Figure 5 | Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model 